Vanguard Portfolio Management
PLSE icon

Vanguard Portfolio Management’s Pulse Biosciences PLSE Stock Holding History

Vanguard Portfolio Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.98M Buy
179,497
+14,296
+9% +$337K ﹤0.01% 2440
2026
Q1 		$3.57M Buy
+165,201
New +$3.05M ﹤0.01% 2431

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Portfolio Management's PLSE Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Pulse Biosciences (PLSE) stake by 8.7% in Q2 2026, buying an estimated $337K and bringing the position to 179,497 shares worth $4.98M. The position accounts for ﹤0.01% of the portfolio, ranked #2440.

Vanguard Portfolio Management first reported a position in PLSE in Q1 2026 and has held it in 2 quarters since. 105 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Vanguard Portfolio Management held 179,497 shares of Pulse Biosciences worth $4.98M as of Q2 2026.
  • Vanguard Portfolio Management bought 14,296 Pulse Biosciences shares in Q2 2026, an estimated $337K.
  • Pulse Biosciences made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2440 holding.
  • Vanguard Portfolio Management first reported a position in Pulse Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 105 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.